Insulin therapy for the management of hyperglycemia in hospitalized patients

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 1, 2012, Pages 175-201

  McDonnell, Marie E ^a   Umpierrez, Guillermo E ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Critical illness; Hospital; Hyperglycemia; Hypoglycemia; Inpatient diabetes; Nutrition

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INTERMEDIATE ACTING INSULIN; ISOPHANE INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PIG INSULIN; SHORT ACTING INSULIN; SULFONYLUREA; UNCLASSIFIED DRUG;

ADD ON THERAPY; BLOOD GLUCOSE MONITORING; DIET THERAPY; DRUG EFFECT; ENTERIC FEEDING; GENERAL PRACTICE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTENSIVE CARE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SURGERY; UNSPECIFIED SIDE EFFECT;

CRITICAL ILLNESS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN;

EID: 84860636729     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.01.001     Document Type: Review

References (170)

1. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355(9206):773-778.
2. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67(2):352-360. [discussion: 360-2].
3. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78(12):1471-1478.
4. Umpierrez G.E., Isaacs S.D., Bazargan N., et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002, 87(3):978-982.
5. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345(19):1359-1367.
6. Weekers F., Giulietti A.P., Michalaki M., et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003, 144(12):5329-5338.
7. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003, 125(5):1007-1021.
8. Jovanovic L., Peterson C.M. Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med 1983, 75(4):607-612.
9. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26(1):57-65.
10. Garber A.J., Moghissi E.S., Bransome E.D., et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004, 10(Suppl 2):4-9.
11. Inzucchi S.E. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006, 355(18):1903-1911.
12. Kavanagh B.P., McCowen K.C. Clinical practice. Glycemic control in the ICU. N Engl J Med 2010, 363(26):2540-2546.
13. Greci L.S., Kailasam M., Malkani S., et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003, 26(4):1064-1068.
14. Moghissi E.S., Hirsch I.B. Hospital management of diabetes. Endocrinol Metab Clin North Am 2005, 34(1):99-116.
15. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354(5):449-461.
16. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360(13):1283-1297.
17. Qaseem A., Humphrey L.L., Chou R., et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011, 154(4):260-267.
18. Moghissi E.S., Korytkowski M.T., DiNardo M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009, 32(6):1119-1131.
19. Turchin A., Matheny M.E., Shubina M., et al. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009, 32(7):1153-1157.
20. Vriesendorp T.M., DeVries J.H., van Santen S., et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006, 34(11):2714-2718.
21. Egi M., Bellomo R., Stachowski E., et al. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010, 85(3):217-224.
22. Kosiborod M., Inzucchi S.E., Goyal A., et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 2009, 301(15):1556-1564.
23. Braithwaite S.S., Magee M., Sharretts J.M., et al. The case for supporting inpatient glycemic control programs now: the evidence and beyond. J Hosp Med 2008, 3(Suppl 5):6-16.
24. Magee M.F., Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract 2004, 10(Suppl 2):81-88.
25. Association AD. Diabetes Statistics. Diabetes Basics. Available at:. Accessed June 11, 2010. http://www.diabetes.org/diabetes-basics/diabetes-statistics/.
26. Jiang H.J., Stryer D., Friedman B., et al. Multiple hospitalizations for patients with diabetes. Diabetes Care 2003, 26(5):1421-1426.
27. Donnan P.T., Leese G.P., Morris A.D. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care 2000, 23(12):1774-1779.
28. Cook C.B., Kongable G.L., Potter D.J., et al. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. J Hosp Med 2009, 4(9):E7-E14.
29. Kosiborod M., Inzucchi S.E., Spertus J.A., et al. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation 2009, 119(14):1899-1907.
30. Schmeltz L.R., DeSantis A.J., Thiyagarajan V., et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007, 30(4):823-828.
31. Sonksen P.H. Home monitoring of blood glucose by diabetic patients. Acta Endocrinol Suppl (Copenh) 1980, 238:145-155.
32. Mazurek J.A., Hailpern S.M., Goring T., et al. Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. J Clin Endocrinol Metab 2010, 95(3):1344-1348.
33. Baldwin D., Villanueva G., McNutt R., et al. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 2005, 28(5):1008-1011.
34. Umpierrez G.E., Kitabchi A.E. ICU care for patients with diabetes. Curr Opin Endocrinol 2004, 11:75-81.
35. McCowen K.C., Malhotra A., Bistrian B.R. Stress-induced hyperglycemia. Crit Care Clin 2001, 17(1):107-124.
36. Corssmit E.P., Romijn J.A., Sauerwein H.P. Review article: regulation of glucose production with special attention to nonclassical regulatory mechanisms: a review. Metabolism 2001, 50(7):742-755.
37. Cryer P.E. Hypoglycemia, functional brain failure, and brain death. J Clin Invest 2007, 117(4):868-870.
38. Boden G. Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 2004, 52(6):375-378.
39. Rizza R.A., Mandarino L.J., Gerich J.E. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981, 240(6):E630-E639.
40. Edgerton D.S., Ramnanan C.J., Grueter C.A., et al. Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. Diabetes 2009, 58(12):2766-2775.
41. Gabbay R.A., Sutherland C., Gnudi L., et al. Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 1996, 271(4):1890-1897.
42. Parks W.C., Drake R.L. Insulin mediates the stimulation of pyruvate kinase by a dual mechanism. Biochem J 1982, 208(2):333-337.
43. Losser M.R., Damoisel C., Payen D. Bench-to-bedside review: glucose and stress conditions in the intensive care unit. Crit Care 2010, 14(4):231.
44. Scherpereel P.A., Tavernier B. Perioperative care of diabetic patients. Eur J Anaesthesiol 2001, 18(5):277-294.
45. Chan T.M. The permissive effects of glucocorticoid on hepatic gluconeogenesis. Glucagon stimulation of glucose-suppressed gluconeogenesis and inhibition of 6-phosphofructo-1-kinase in hepatocytes from fasted rats. J Biol Chem 1984, 259(12):7426-7432.
46. McMahon M., Gerich J., Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 1988, 4(1):17-30.
47. Esposito K., Nappo F., Marfella R., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106(16):2067-2072.
48. Stentz F.B., Umpierrez G.E., Cuervo R., et al. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004, 53(8):2079-2086.
49. Lang C.H., Dobrescu C., Bagby G.J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992, 130(1):43-52.
50. Fan J., Li Y.H., Wojnar M.M., et al. Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock 1996, 6(3):164-170.
51. del Aguila L.F., Claffey K.P., Kirwan J.P. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol 1999, 276(5 Pt 1):E849-E855.
52. Edwards F.H., Grover F.L., Shroyer A.L., et al. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 1997, 63(3):903-908.
53. Clement S., Braithwaite S.S., Magee M.F., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004, 27(2):553-597.
54. Bagdade J.D., Root R.K., Bulger R.J. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974, 23(1):9-15.
55. Garg R., Chaudhuri A., Munschauer F., et al. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2006, 37(1):267-273.
56. Valko M., Leibfritz D., Moncol J., et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84.
57. Rains J.L., Jain S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011, 50(5):567-575.
58. Kersten J.R., Montgomery M.W., Ghassemi T., et al. Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 2001, 280(4):H1744-H1750.
59. Ceriello A., Quagliaro L., D'Amico M., et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002, 51(4):1076-1082.
60. Title L.M., Cummings P.M., Giddens K., et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 2000, 36(7):2185-2191.
61. Gresele P., Guglielmini G., De Angelis M., et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003, 41(6):1013-1020.
62. Pandolfi A., Giaccari A., Cilli C., et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 2001, 38(2):71-76.
63. Oswald G.A., Smith C.C., Betteridge D.J., et al. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986, 293(6552):917-922.
64. Norhammar A.M., Ryden L., Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999, 22(11):1827-1831.
65. Trence D.L., Kelly J.L., Hirsch I.B. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab 2003, 88(6):2430-2437.
66. Steinberg H.O., Tarshoby M., Monestel R., et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997, 100(5):1230-1239.
67. Oliver M.F., Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994, 343(8890):155-158.
68. Robinson L.E., van Soeren M.H. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004, 15(1):45-62.
69. Pulsinelli W.A., Levy D.E., Sigsbee B., et al. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983, 74(4):540-544.
70. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32(10):2426-2432.
71. Kawai N., Keep R.F., Betz A.L. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 1997, 28(1):149-154.
72. Prado R., Ginsberg M.D., Dietrich W.D., et al. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab 1988, 8(2):186-192.
73. Kruyt N.D., Biessels G.J., Devries J.H., et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010, 6(3):145-155.
74. Quast M.J., Wei J., Huang N.C., et al. Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats. J Cereb Blood Flow Metab 1997, 17(5):553-559.
75. Furnary A.P., Wu Y., Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004, 10(Suppl 2):21-33.
76. Falciglia M., Freyberg R.W., Almenoff P.L., et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009, 37(12):3001-3009.
77. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004, 109(12):1497-1502.
78. Goyal A., Mahaffey K.W., Garg J., et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006, 27(11):1289-1297.
79. Mazighi M., Labreuche J., Amarenco P. Glucose level and brain infarction: a prospective case-control study and prospective study. Int J Stroke 2009, 4(5):346-351.
80. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358(2):125-139.
81. De La Rosa Gdel C., Donado J.H., Restrepo A.H., et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008, 12(5):R120.
82. Preiser J.C., Brunkhorst F. Tight glucose control and hypoglycemia. Crit Care Med 2008, 36(4):1391. [author reply: 1391-2].
83. Griesdale D.E., de Souza R.J., van Dam R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180(8):821-827.
84. Montori V.M., Bistrian B.R., McMahon M.M. Hyperglycemia in acutely ill patients. JAMA 2002, 288(17):2167-2169.
85. McAlister F.A., Majumdar S.R., Blitz S., et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005, 28(4):810-815.
86. Baker E.H., Janaway C.H., Philips B.J., et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006, 61(4):284-289.
87. Frisch A., Chandra P., Smiley D., et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 2010, 33(8):1783-1788.
88. Turnbull P.J., Sinclair A.J. Evaluation of nutritional status and its relationship with functional status in older citizens with diabetes mellitus using the mini nutritional assessment (MNA) tool-a preliminary investigation. J Nutr Health Aging 2002, 6(3):185-189.
89. Pomposelli J.J., Baxter J.K., Babineau T.J., et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998, 22(2):77-81.
90. Noordzij P.G., Boersma E., Schreiner F., et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 2007, 156(1):137-142.
91. Ramos M., Khalpey Z., Lipsitz S., et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008, 248(4):585-591.
92. Hirsch I.B., McGill J.B. Role of insulin in management of surgical patients with diabetes mellitus. Diabetes Care 1990, 13(9):980-991.
93. Dandona P., Aljada A., Mohanty P., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 2001, 86(7):3257-3265.
94. Aljada A., Ghanim H., Mohanty P., et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 2002, 87(3):1419-1422.
95. Dandona P., Aljada A., Bandyopadhyay A. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia. Diabetes Care 2003, 26(2):516-519.
96. Moghissi E.S., Korytkowski M.T., DiNardo M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009, 15(4):353-369.
97. American Diabetes Association Standards of medical care in diabetes-2011. Diabetes Care 2011, 34(Suppl 1):S11-S61.
98. Levetan C.S., Magee M.F. Hospital management of diabetes. Endocrinol Metab Clin North Am 2000, 29(4):745-770.
99. Levetan C.S., Passaro M., Jablonski K., et al. Unrecognized diabetes among hospitalized patients. Diabetes Care 1998, 21(2):246-249.
100. Ben-Ami H., Nagachandran P., Mendelson A., et al. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 1999, 159(3):281-284.
101. Donihi A.C., Raval D., Saul M., et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 2006, 12(4):358-362.
102. Korytkowski M., Dinardo M., Donihi A.C., et al. Evolution of a diabetes inpatient safety committee. Endocr Pract 2006, 12(Suppl 3):91-99.
103. Juneja R., Foster S.A., Whiteman D., et al. The nuts and bolts of subcutaneous insulin therapy in non-critical care hospital settings. Postgrad Med 2010, 122(1):153-162.
104. Smiley D., Rhee M., Peng L., et al. Safety and efficacy of continuous insulin infusion in noncritical care settings. J Hosp Med 2010, 5(4):212-217.
105. Seley J.J., D'Hondt N., Longo R., et al. Position statement: inpatient glycemic control. Diabetes Educ 2009, 35(Suppl 3):65-69.
106. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl 1):S11-S61.
107. Dungan K., Chapman J., Braithwaite S.S., et al. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007, 30(2):403-409.
108. Scott M.G., Bruns D.E., Boyd J.C., et al. Tight glucose control in the intensive care unit: are glucose meters up to the task?. Clin Chem 2009, 55(1):18-20.
109. Kanji S., Buffie J., Hutton B., et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005, 33(12):2778-2785.
110. Schafer R.G., Bohannon B., Franz M.J., et al. Diabetes nutrition recommendations for health care institutions. Diabetes Care 2004, 27(Suppl 1):S55-S57.
111. McMahon M.M., Rizza R.A. Nutrition support in hospitalized patients with diabetes mellitus. Mayo Clin Proc 1996, 71(6):587-594.
112. Bantle J.P., Wylie-Rosett J., Albright A.L., et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl 1):S61-S78.
113. McClave S.A., Martindale R.G., Vanek V.W., et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009, 33(3):277-316.
114. Warren J., Bhalla V., Cresci G. Postoperative diet advancement: surgical dogma vs evidence-based medicine. Nutr Clin Pract 2011, 26(2):115-125.
115. Kreymann K.G., Berger M.M., Deutz N.E., et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 2006, 25(2):210-223.
116. Via M.A., Mechanick J.I. Inpatient enteral and parental nutrition for patients with diabetes. Curr Diab Rep 2010, 11(2):99-105.
117. Craig L.D., Nicholson S., SilVerstone F.A., et al. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 1998, 14(6):529-534.
118. Leon-Sanz M., Garcia-Luna P.P., Sanz-Paris A., et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). JPEN J Parenter Enteral Nutr 2005, 29(1):21-29.
119. Elia M., Ceriello A., Laube H., et al. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 2005, 28(9):2267-2279.
120. Heyland D.K., Montalvo M., MacDonald S., et al. Total parenteral nutrition in the surgical patient: a meta-analysis. Can J Surg 2001, 44(2):102-111.
121. Ziegler T.R. Parenteral nutrition in the critically ill patient. N Engl J Med 2009, 361(11):1088-1097.
122. Muller J.M., Brenner U., Dienst C., et al. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet 1982, 1(8263):68-71.
123. Brady P.A., Terzic A. The sulfonylurea controversy: more questions from the heart. J Am Coll Cardiol 1998, 31(5):950-956.
124. Meinert C.L., Knatterud G.L., Prout T.E., et al. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970, 19(Suppl):789-830.
125. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5):1124-1136.
126. Deutsch E., Berger M., Kussmaul W.G., et al. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1990, 82(6):2044-2051.
127. Terzic A., Jahangir A., Kurachi Y. Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs. Am J Physiol 1995, 269(3 Pt 1):C525-C545.
128. Horlen C., Malone R., Bryant B., et al. Frequency of inappropriate metformin prescriptions. JAMA 2002, 287(19):2504-2505.
129. Delea T.E., Edelsberg J.S., Hagiwara M., et al. Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care 2003, 26(11):2983-2989.
130. Nesto R.W., Bell D., Bonow R.O., et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care 2004, 27(1):256-263.
131. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368(9548):1696-1705.
132. Goldberg P.A., Siegel M.D., Sherwin R.S., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004, 27(2):461-467.
133. Krikorian A., Ismail-Beigi F., Moghissi E.S. Comparisons of different insulin infusion protocols: a review of recent literature. Curr Opin Clin Nutr Metab Care 2010, 13(2):198-204.
134. Donihi A., Rea R., Haas L., et al. Safety and effectiveness of a standardized 80-150mg/dl iv insulin infusion protocol in the Medical Intensive care unit: >11,000 hours of experience. Diabetes 2006, 55(Suppl 1):459-P.
135. Davidson P.C., Steed R.D., Bode B.W. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 2005, 28(10):2418-2423.
136. Juneja R., Roudebush C., Kumar N., et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther 2007, 9(3):232-240.
137. Newton C.A., Smiley D., Bode B.W., et al. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms. J Hosp Med 2010, 5(8):432-437.
138. Dossett L.A., Cao H., Mowery N.T., et al. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008, 74(8):679-685. [discussion: 685].
139. DeSantis A.J., Schmeltz L.R., Schmidt K., et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract 2006, 12(5):491-505.
140. Rea R.S., Donihi A.C., Bobeck M., et al. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm 2007, 64(4):385-395.
141. Akhtar S., Barash P.G., Inzucchi S.E. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg 2010, 110(2):478-497.
142. Kitabchi A.E., Umpierrez G.E., Miles J.M., et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009, 32(7):1335-1343.
143. Mao C.S., Riegelhuth M.E., Van Gundy D., et al. An overnight insulin infusion algorithm provides morning normoglycemia and can be used to predict insulin requirements in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997, 82(8):2466-2470.
144. O'Malley C.W., Emanuele M., Halasyamani L., et al. Bridge over troubled waters: safe and effective transitions of the inpatient with hyperglycemia. J Hosp Med 2008, 3(Suppl 5):55-65.
145. Donaldson S., Villanuueva G., Rondinelli L., et al. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ 2006, 32(6):954-962.
146. Schmeltz L.R., DeSantis A.J., Schmidt K., et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract 2006, 12(6):641-650.
147. Grainger A., Eiden K., Kemper J., et al. A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit. Nutr Clin Pract 2007, 22(5):545-552.
148. Avanzini F., Marelli G., Donzelli W., et al. Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diabetes Care 2011, 34(7):1445-1450.
149. King A.B., Armstrong D.U. Basal bolus dosing: a clinical experience. Curr Diabetes Rev 2005, 1(2):215-220.
150. Umpierrez G., Maynard G. Glycemic chaos (not glycemic control) still the rule for inpatient care: how do we stop the insanity?. J Hosp Med 2006, 1(3):141-144.
151. Hirsch I.B. Sliding scale insulin-time to stop sliding. JAMA 2009, 301(2):213-214.
152. Umpierrez G.E., Palacio A., Smiley D. Sliding scale insulin use: myth or insanity?. Am J Med 2007, 120(7):563-567.
153. Umpierrez G.E., Smiley D., Zisman A., et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007, 30(9):2181-2186.
154. Umpierrez E., Smiley D., Jacobs S., et al. Randomized study of basal bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011, 34(2):256-261.
155. Hor T., Smiley D., Munoz C., et al. Comparison of inpatient insulin regimens: DEtemir plus Aspart vs. NPH plus regular in Medical Patients with Type 2 Diabetes (DEAN Trial). Diabetes 2008, 57(Suppl 1):458A.
156. Maynard G., Lee J., Phillips G., et al. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med 2009, 4(1):3-15.
157. Pietras S.M., Hanrahan P., Arnold L.M., et al. State-of-the-art inpatient diabetes care: the evolution of an academic hospital. Endocr Pract 2010, 16(3):512-521.
158. Cryer P.E., Axelrod L., Grossman A.B., et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009, 94(3):709-728.
159. Krinsley J.S., Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007, 35(10):2262-2267.
160. Kagansky N., Levy S., Rimon E., et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med 2003, 163(15):1825-1829.
161. Smith W.D., Winterstein A.G., Johns T., et al. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm 2005, 62(7):714-719.
162. Zoungas S., Patel A., Chalmers J., et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010, 363(15):1410-1418.
163. Preiser J.C., Devos P., Ruiz-Santana S., et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35(10):1738-1748.
164. Wiener R.S., Wiener D.C., Larson R.J. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300(8):933-944.
165. Arabi Y.M., Tamim H.M., Rishu A.H. Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 2009, 37(9):2536-2544.
166. Krinsley J.S., Schultz M.J., Spronk P.E., et al. Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care 2011, 15(4):R173.
167. Boucai L., Southern W.N., Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med 2011, 124(11):1028-1035.
168. Farah R., Samokhvalov A., Zviebel F., et al. Insulin therapy of hyperglycemia in intensive care. Isr Med Assoc J 2007, 9(3):140-142.
169. Grey N.J., Perdrizet G.A. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004, 10(Suppl 2):46-52.
170. Mackenzie I.M., Ercole A., Blunt M., et al. Glycaemic control and outcome in general intensive care: the East Anglian GLYCOGENIC study. Br J Intensive Care 2008, 18:121-126.